Cell Signaling Technology

Tunicamycin

#12819 · $164

100
Citing papers
4.5k
Combined citations
Supplier page Find this product

Research areas

Cell death mechanisms and regulation17PI3K/AKT/mTOR signaling in cancer9Autophagy in Disease and Therapy8Platelet Disorders and Treatments6Ubiquitin and proteasome pathways6Cancer, Hypoxia, and Metabolism6Cell Adhesion Molecules Research5interferon and immune responses5

Papers citing this product

1
Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway
Cell Death and Differentiation·2009·245 cit.·DOI
2
miR-29b contributes to multiple types of muscle atrophy
Nature Communications·2017·245 cit.·DOI
3
Inflammatory Stimuli Regulate Caspase Substrate Profiles
Molecular & Cellular Proteomics·2010·218 cit.·DOI
4
Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy
Evidence-based Complementary and Alternative Medicine·2012·214 cit.·DOI
5
A Caspase Cascade Regulating Developmental Axon Degeneration
Journal of Neuroscience·2012·207 cit.·DOI
6
The E3 Ubiquitin Ligase cIAP1 Binds and Ubiquitinates Caspase-3 and -7 via Unique Mechanisms at Distinct Steps in Their Processing
Journal of Biological Chemistry·2009·171 cit.·DOI
7
Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases
Nature Communications·2021·167 cit.·DOI
8
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
Journal of Clinical Investigation·2018·135 cit.·DOI
9
LncRNA NKILA suppresses TGF‐β‐induced epithelial–mesenchymal transition by blocking NF‐κB signaling in breast cancer
International Journal of Cancer·2018·129 cit.·DOI
10
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach
Cell Death and Disease·2016·120 cit.·DOI
Tunicamycin — Evidence — PubIndex